Literature DB >> 11238054

Structural and functional disruption of vascular smooth muscle cells in a transgenic mouse model of amyloid angiopathy.

R Christie1, M Yamada, M Moskowitz, B Hyman.   

Abstract

The deposition of amyloid Abeta peptide in the wall of cerebral vessels (cerebral amyloid angiopathy), can lead to weakness and rupture of the vessel wall, resulting in hemorrhagic stroke. The Tg2576 transgenic mouse line, overexpressing mutant amyloid precursor protein in an age-dependent manner, forms amyloid angiopathy morphologically similar to that seen in the human. We report here the structural and functional disruption of smooth muscle cells (SMCs) in the walls of pial vessels affected by amyloid deposition in the Tg2576 mouse. We demonstrate, using multiphoton imaging, that the arrangement of SMCs becomes disorganized before the onset of cell death, and that these disorganized SMCs are unable to respond appropriately to application of endothelial-dependent and endothelial-independent vasodilators in a closed-cranial window preparation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11238054      PMCID: PMC1850363          DOI: 10.1016/S0002-9440(10)64053-9

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  20 in total

1.  Toxicity of Dutch (E22Q) and Flemish (A21G) mutant amyloid beta proteins to human cerebral microvessel and aortic smooth muscle cells.

Authors:  Z Wang; R Natté; J A Berliner; S G van Duinen; H V Vinters
Journal:  Stroke       Date:  2000-02       Impact factor: 7.914

2.  Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model.

Authors:  D M Holtzman; A M Fagan; B Mackey; T Tenkova; L Sartorius; S M Paul; K Bales; K H Ashe; M C Irizarry; B T Hyman
Journal:  Ann Neurol       Date:  2000-06       Impact factor: 10.422

3.  Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid.

Authors:  M E Calhoun; P Burgermeister; A L Phinney; M Stalder; M Tolnay; K H Wiederhold; D Abramowski; C Sturchler-Pierrat; B Sommer; M Staufenbiel; M Jucker
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

4.  Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse.

Authors:  D Schenk; R Barbour; W Dunn; G Gordon; H Grajeda; T Guido; K Hu; J Huang; K Johnson-Wood; K Khan; D Kholodenko; M Lee; Z Liao; I Lieberburg; R Motter; L Mutter; F Soriano; G Shopp; N Vasquez; C Vandevert; S Walker; M Wogulis; T Yednock; D Games; P Seubert
Journal:  Nature       Date:  1999-07-08       Impact factor: 49.962

5.  Soluble beta-amyloid peptides mediate vasoactivity via activation of a pro-inflammatory pathway.

Authors:  D Paris; T Town; T Mori; T A Parker; J Humphrey; M Mullan
Journal:  Neurobiol Aging       Date:  2000 Mar-Apr       Impact factor: 4.673

6.  A pulmonary artery endothelial factor causes unidirectional alignment of smooth muscle cells.

Authors:  W Wilson; T Bothwell; M Rabinovitch
Journal:  Tissue Cell       Date:  1987       Impact factor: 2.466

7.  Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study.

Authors:  J P Vonsattel; R H Myers; E T Hedley-Whyte; A H Ropper; E D Bird; E P Richardson
Journal:  Ann Neurol       Date:  1991-11       Impact factor: 10.422

8.  ATP-sensitive K+ channels mediate dilatation of cerebral arterioles during hypoxia.

Authors:  H Taguchi; D D Heistad; T Kitazono; F M Faraci
Journal:  Circ Res       Date:  1994-05       Impact factor: 17.367

9.  Altered cleavage and secretion of a recombinant beta-APP bearing the Swedish familial Alzheimer's disease mutation.

Authors:  K M Felsenstein; L W Hunihan; S B Roberts
Journal:  Nat Genet       Date:  1994-03       Impact factor: 38.330

10.  Microvasculature in brain biopsy specimens from patients with Alzheimer's disease: an immunohistochemical and ultrastructural study.

Authors:  H V Vinters; D L Secor; S L Read; J G Frazee; U Tomiyasu; T M Stanley; J A Ferreiro; M A Akers
Journal:  Ultrastruct Pathol       Date:  1994 May-Jun       Impact factor: 1.094

View more
  47 in total

1.  Amyloid-β contributes to blood-brain barrier leakage in transgenic human amyloid precursor protein mice and in humans with cerebral amyloid angiopathy.

Authors:  Anika M S Hartz; Björn Bauer; Emma L B Soldner; Andrea Wolf; Sandra Boy; Roland Backhaus; Ivan Mihaljevic; Ulrich Bogdahn; Hans H Klünemann; Gerhard Schuierer; Felix Schlachetzki
Journal:  Stroke       Date:  2011-11-23       Impact factor: 7.914

Review 2.  APP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD).

Authors:  R Lalonde; K Fukuchi; C Strazielle
Journal:  Neurosci Biobehav Rev       Date:  2012-02-21       Impact factor: 8.989

Review 3.  Techniques for brain imaging in vivo.

Authors:  Monica Garcia-Alloza; Brian J Bacskai
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

4.  Peripherally administered human umbilical cord blood cells reduce parenchymal and vascular beta-amyloid deposits in Alzheimer mice.

Authors:  William V Nikolic; Huayan Hou; Terrence Town; Yuyan Zhu; Brian Giunta; Cyndy D Sanberg; Jin Zeng; Deyan Luo; Jared Ehrhart; Takashi Mori; Paul R Sanberg; Jun Tan
Journal:  Stem Cells Dev       Date:  2008-06       Impact factor: 3.272

5.  Cerebrovascular dysfunction in amyloid precursor protein transgenic mice: contribution of soluble and insoluble amyloid-beta peptide, partial restoration via gamma-secretase inhibition.

Authors:  Byung Hee Han; Meng-Liang Zhou; Fadi Abousaleh; Robert P Brendza; Hans H Dietrich; Jessica Koenigsknecht-Talboo; John R Cirrito; Eric Milner; David M Holtzman; Gregory J Zipfel
Journal:  J Neurosci       Date:  2008-12-10       Impact factor: 6.167

6.  Compromised hemodynamic response in amyloid precursor protein transgenic mice.

Authors:  Thomas Mueggler; Christine Sturchler-Pierrat; Diana Baumann; Martin Rausch; Matthias Staufenbiel; Markus Rudin
Journal:  J Neurosci       Date:  2002-08-15       Impact factor: 6.167

Review 7.  Linking vascular disorders and Alzheimer's disease: potential involvement of BACE1.

Authors:  Sarah L Cole; Robert Vassar
Journal:  Neurobiol Aging       Date:  2008-03-04       Impact factor: 4.673

8.  Mitochondrial superoxide contributes to blood flow and axonal transport deficits in the Tg2576 mouse model of Alzheimer's disease.

Authors:  Cynthia A Massaad; Samir K Amin; Lingyun Hu; Yuan Mei; Eric Klann; Robia G Pautler
Journal:  PLoS One       Date:  2010-05-10       Impact factor: 3.240

9.  Soluble amyloid-beta, effect on cerebral arteriolar regulation and vascular cells.

Authors:  Hans H Dietrich; Chuanxi Xiang; Byung H Han; Gregory J Zipfel; David M Holtzman
Journal:  Mol Neurodegener       Date:  2010-04-13       Impact factor: 14.195

10.  Mutant presenilin-1 deregulated peripheral immunity exacerbates Alzheimer-like pathology.

Authors:  Yuyan Zhu; Demian Obregon; Huayan Hou; Brian Giunta; Jared Ehrhart; Frank Fernandez; Takashi Mori; William Nikolic; Yangbing Zhao; Dave Morgan; Terrence Town; Jun Tan
Journal:  J Cell Mol Med       Date:  2011-02       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.